FanPep, Kids Bio, and others.
The forecast for this period's operating profit has been revised down to 0.39 billion yen from 1.619 billion yen.
March 28 [Today's Investment Strategy]
[Fisco Selected Stocks] [Materials Stock] Migaro Holdings <5535> 2555 yen (3/27) is engaged in the development of investment condominiums, etc. It has been announced that the company will split one share into two shares with May 31, 2025, as the record date. The company aims to improve liquidity and increase Volume by expanding its investor base, having already split one share into two on February 28, 2025, but the stock price has risen since the last split decision, thus the policy of expanding the investor base.
The market is soft, and with pressures like the decline in U.S. stocks, but the downside may be limited.
[Emerging Markets Individual Stocks Global Strategy] Today's Emerging Markets are expected to show a sluggish development. In the US stock market on the 27th, the Dow Inc. fell by 155.09 points (-0.37%) to 42,299.70 dollars, continuing its decline. Concerns over the automobile tariffs announced by President Trump, along with speculation of persistent high inflation, led to a dislike of rising long-term interest rates. On the other hand, indicators such as employment-related data and gross domestic product (GDP) pointed to a robust economy, causing the Dow Inc. to briefly turn upward, but uncertainty regarding tariffs lingered towards the end.
<Today's individual materials> Cookpad, Veru Inc, Material, JCR Pharma, etc. (Announced on 27th)
▽ Cookpad <2193.T> has set a limit of 20 million shares (24.2% of the total issued shares excluding treasury stock) and a 2 billion yen treasury stock purchase framework, planning to retire 18 million shares along with all shares acquired. ▽ Vertex <5290.T> has acquired shares of IHI <7013.T>'s subsidiary IHI Building Materials and has made it a subsidiary. ▽ Metarial <6182.T> has revised its consolidated performance Financial Estimates for the fiscal year ending February 2025 downward. ▽ JCR Pharma <4552.T> has lowered its consolidated performance Financial Estimates for the fiscal year ending March 2025.
Ribomic, BTM and others [Emerging Markets press release]
<290A> Recognized approximately 0.017 billion yen in subsidy income as non-operating revenue. <4316> Acquired real estate for sale in Beemap (land in Kawasaki City, Kanagawa Prefecture). <4379> Completed the acquisition of treasury stock for Photosync. <4591> Released the results of joint research on ANCA-related vasculitis with Hokkaido Universities and concluded the joint research contract. <5070> Established a subsidiary, Draft. <5247> Acquired shares of a company engaged in the design, manufacturing, sales, and maintenance of BTM Computer software.
Attention points for the PTS on the 27th = Fuji HD, Kameda Confectionery, Takeuchi Manufacturing, etc.
▽ Fuji HD <4676.T> announced changes in the representative director and the board structure of the company and Fuji Television. ▽ Kameda Confectionery <2220.T> acquired shares of TH FOOS, a company accounted for by the equity method in the USA, and made it a consolidated subsidiary. ▽ Furukawa Machinery <5715.T> acquired shares of Mitsui Miike Manufacturing (Chuo Ward, Tokyo) and made it a company accounted for by the equity method. ▽ Ribomic <4591.T> announced the results of joint research with Hokkaido Universities on ANCA-related vasculitis. ▽ Cast Iron Pipe <5612>
tripla, Daiwa Cycle and others
<184A> The revised forecast for the learning aid has been adjusted downward, with an operating loss outlook of △0.299 billion yen, down from 0.2 billion yen. <286A> Acquired stocks of Gplus, which engages in Yukaria A-REIT ETF inheritance consulting, making it a wholly-owned subsidiary. <4014> Concluded a memorandum regarding the consideration of a business partnership with Sumitomo Life Insurance Mutual Company, which operates in the Insurance business. <4169> Recorded a subsidy income from Enechange of 4.676 billion yen as non-operating income. <4591> Ribomic JST・CREST "AI App.
Afternoon session [Active stocks and traded stocks]
*JR East <9020> 3058 +88 Domestic securities have upgraded their investment judgment and Target Price. *Migaro HD <5535> 2125 +163 The Facial Recognition platform 'FreeiD' has been decided to be introduced to MITSUBISHI ESTATE Residence 'The Park Habio Nagoya Matsubara'. *Yukus <4334> 398 +21 Operating profit decreased by 51.1% compared to the previous term, but it is expected to be 3.9 times this term. *Alpico HD <297A> 264 +172 A commemorative Dividends will be implemented at the end of the fiscal year in March 2025. *Dub
Ribomic and other ETC [stocks of interest viewed from volume change]
Stock closing price, compared to the previous day, Volume * <6029> Atora G 1230727700 * <9761> Tokai Lease 2175332258600 * <4422> VALUE NEX 6878847700 * <2673> Dream Finding Team 1001821700 * <4265> IGS 27924211500 * <4591> Ribomic 1181223479000 * <5578> AR Advanced 172511049100 * <7044> Piala 24712205100 * <2
Ribomic, etc. continues to rank, and is developing a dynamic extension technology in joint research and development with Ajinomoto, with a patent application.
Ribomic <4591> is ranked (as of 2:32 PM). There has been a sharp rise. It announced after the end of the previous day's Trade that a technology for prolonging dynamics using antibody Fc region fusion has been developed in collaboration with Ajinomoto <2802>, and a patent application has been filed with the Japan Patent Office. This is a patent concerning the conjugate of nucleic acid aptamers and immunoglobulin Fc regions and its extension of half-life in the bloodstream. Highest change rate in Volume [As of March 12, 2:32 PM] (compared to the average Volume over the last 5 days) Code Company Volume 5.
Stocks that moved or were traded in the first half of the session.
*World <3612> 2642 +233 Mizuho Securities has raised the Target Price. *Naiwai Transline <9384> 4045 +340 The TOB price of 4065 yen by IA Partners continues to converge. *Japan Hume <5262> 2136 +144 The upward movement continues as a measure related to water pipes. *Peptidream <4587> 2173 +147.5 SBI Securities has raised the Target Price. *Rakuten Bank <5838> 6000 +369 Mo
Ribomic surges to last year's high, seen as a material related to patent application.
Ribomic <4591.T> surged sharply. At one point, it rose by 30 yen to 136 yen, significantly updating the last year's high of 124 yen on February 19. After the market closed on the 11th, it was announced that a patent application regarding the conjugate of nucleic acid aptamers and the Fc region of immunoglobulin, as well as its blood half-life extension, was filed with Japan's Patent Office, which was seen as a material factor. The company is conducting joint research aimed at realizing next-generation aptamer Pharmaceuticals in collaboration with Ajinomoto <2802.T>. The technology for which the patent has been applied is a conventional poly.
March 12 [Today's Investment Strategy]
[Fisco Selected Stocks] [Material Stocks] THE Global Corporation <3271> 728 yen (3/11) plans and develops condominiums, income properties, commercial facilities, etc. in the metropolitan and Kansai areas. It was announced that a business capital alliance with Asahi Kasei Homes will be established. Asahi Kasei Homes will acquire 9.88% of the stocks of THE Global Corporation from existing shareholders. Joint development of large-scale condominium projects in the metropolitan area, effective utilization of real estate development information, and cost synergies in condominium-related businesses are anticipated.
Soft trends and a decline in U.S. stocks are burdensome, but there may be a firm bottom in the market.
[Emerging Markets Individual Stock Global Strategy] Today's emerging markets are expected to show a downward trend. Yesterday, on the 11th, the US Stocks market saw the Dow Inc drop by 478.23 points (-1.14%) to 41,433.48, continuing its significant decline. President Trump warned of increased tariffs on Canadian Iron & Steel and Aluminum, heightening concerns about trade friction impacting stock prices. Towards the end, reports emerged that Ukraine is willing to accept a ceasefire proposal, raising hopes for a ceasefire, and following discussions with Canada, trade
<Today's individual materials> Azone, Burniba, REVOLU, Silver Life ETC (announced on the 11th)
▽ As-One <7476.T> has revised the Financial Estimates for the year-end Dividends for the fiscal year ending March 2025 from 29 yen to 34 yen (previous fiscal year result 31 yen). ▽ Balnibarbi <3418.T> has resolved to acquire Stocks of Enabi-Due (Minato-ku, Tokyo) and make it a subsidiary. ▽ REVOLU <8894.T> has abolished its Shareholder benefits program. ▽ Silver Life <9262.T> has reported an increase in revenue but a decrease in profit for the consolidated financial results for the second quarter of the fiscal year ending July 2025 (August 2024 - January 2025). ▽ Tokai Lease <9761.T>, fiscal year ending March 2025.
Ribomic, Barunibabi, and others.
Acquired shares of Enabiru Doo, which engages in the sale, rental, management, Shareholding, and disposal of Valuni Babi A-REIT ETF <3418>. Completed the development and patent application of the antibody Fc domain fusion-based pharmacokinetic extension technology in collaboration with Ajinomoto <2802> and Ribomic <4591>. Eco Leather, a consolidated subsidiary of Technologies <5248>, has formed a business alliance with West Holdings <1407>. Issued new shares through third-party allocation (2.75 million shares) in the 4th new share subscription by ispace <9348>.
Key points of the PTS on the 11th = Tokai Lease, Daiseki, CRE, ETC.
▽ Tokai Lease <9761.T> revises upward its consolidated financial estimates and dividend forecasts for the fiscal year ending March 2025. ▽ Omori Corporation <1844.T> revises upward its consolidated profit estimates for the cumulative second quarter of the fiscal year ending July 2025 (August 2024 - January 2025). ▽ CRE <3458.T> shows significant profit increase for the consolidated results of the cumulative second quarter of the fiscal year ending July 2025 (August 2024 - January 2025). ▽ AZ One <7476.T> revises upward its dividend forecasts for the fiscal year ending March 2025 and announces some changes to its shareholder benefit program. ▽ Global <3271.T>, Asahi.
Ribomic Inc. Reports Improved Financial Results for Nine Months Ending December 2024
Ribomic Sees FY Loss Y1.40B
Ribomic 9-Mos Parent Loss Y740.00M Vs Loss Y802.00M